Robotic versus Electromagnetic bronchoscopy for pulmonary LesIon AssessmeNT: the RELIANT pragmatic randomized trial.

"Declarations Ethics approval and consent to participate {24}The study has been approved by the Vanderbilt University Medical Center Institutional Review Board (IRB 221255).Written informed consent will be obtained from all study participants. Consent for publication {32}A copy of the written informed consent can be provided if requested. Competing interests {28}RP, RJL, CS, JKS, SWL, JDC, HC, SCC, SA, SS, CJL, CLG, and TWR declare no competing interests.OBR declares: consultant, research grant, and advisory board Medtronic, and consultant, physician advisory board Intuitive.FM declares: research funding to my institution for the VERITAS randomized controlled trial and prior consulting for Medtronic and Intuitive. Competing interests {28} RP, RJL, CS, JKS, SWL, JDC, HC, SCC, SA, SS, CJL, CLG, and TWR declare no competing interests. OBR declares: consultant, research grant, and advisory board Medtronic, and consultant, physician advisory board Intuitive. FM declares: research funding to my institution for the VERITAS randomized controlled trial and prior consulting for Medtronic and Intuitive."

"Funding {4} Pierre Massion Endowed Directorship in Pulmonary Disease to Fabien Maldonado MD, MSc The project described was supported by the VICTR Learning Healthcare System Platform under CTSA award No. 5UL1 TR002243-07 from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health"

"Trial registration ClinicalTrials.gov registration (NCT05705544) on January 30, 2023."